U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231900) titled 'Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients' on Nov. 14.
Brief Summary: The study is designed to diminish intra-dialytic hypertension in chrnic hemodialysis patients suffering from metabolic acidosis (low bicarbonate levels). The intervention is a tab of 500 mg sodium bicarbonate twice a day for one month, vs. placebo.
Study Start Date: Nov. 10
Study Type: INTERVENTIONAL
Condition:
Hypertension in Dialysis Patients
Intervention:
DRUG: Sodium Bicarbonate (NaHCO3)
Prescribing Sodium Bicaronate for intra-dualytic hypertension
DRUG: Placebo
1 tab X 2/day
Recruitment Status: NOT_YET_RECRUI...